Casein kinase 1 delta/epsilon inhibitor - Alchemedicine

Alternative Names: CK1δ/ε inhibitor - Alchemedicine

Latest Information Update: 16 Oct 2023

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Alchemedicine
Class Sleep disorder therapies; Small molecules
Mechanism of Action Casein kinase 1 epsilon inhibitors; Casein kinase Idelta inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes
Available For Licensing Yes

10 Oct 2023 Casein kinase 1 delta/epsilon inhibitor - Alchemedicine is available for licensing as of 10 Oct 2023. https://alchemedicine.com/en/company
03 Oct 2023 Early research in Circadian rhythm sleep disorders in Japan (unspecified route), prior to October 2023 (Alchemedicine pipeline, October 2023)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com